摘要
近年来,随着《中华人民共和国中医药法》的贯彻实施,经典名方制剂简化注册政策法规和目录渐次颁布,经典名方制剂备受中药界关注。日本汉方制剂与我国中药经典名方制剂在很多方面存在一定的相似性,其产业发展历程值得借鉴。该文从生产质量管控、研发注册审批及品种等方面就日本汉方药的产业发展现状和趋势进行分析研究,为我国的经典名方研究开发和产业宏观布局提供参考。
In recent years,with the implementation of the "Chinese Medicine Law",the simplified registration policies,regulations,and catalogues for classic prescription preparations have gradually been promulgated. The classical prescription: preparations have attracted the attention of the Chinese medicine industry. There are certain similarities between Japan's Kampo preparations and the classic Chinese herbal preparations,and its industrial development process is worth learning from. This article analyzes and studies the status quo and trends of the Japanese Kampo medicine industry development,and provides reference for China's classic prescription research and development and industrial macro layout.
作者
丁腾
李耿
张红
彭修娟
党艳妮
王乐
刘峰
DING Teng;LI Geng;ZHANG Hong;PENG Xiu-juan;DANG Yan-ni;WANG Le;LIU Feng(Shaanxi University of Chinese Medicine,Xianyang 712046,China;China-Japan Friendship Hospital,Beijing 100029,China;Shaanxi Academy of Traditional Chinese Medicine,Xi' an 710003,China;Shaanxi Institute of international Trade & Commerce,Xianyang 712046,China;Shaanxi Buchang Pharmaceutical Limited Company,Xi ' an 710075,China;Collaborative Innovation Center of Green Manufacturing Technology for Traditional Chinese Medicine in Shaanxi Province,Xianyang 712046,China)
出处
《中国现代中药》
CAS
2018年第7期785-790,共6页
Modern Chinese Medicine
基金
国家"重大新药创制"科技重大专项(2018ZX09721005-009-013)
关键词
汉方药产业
经典名方
中药
汉方制剂
Kampo medicine industry
classic prescription
traditional Chinese medicine
Japanese Kampo preparations